<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25857692</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1579-2021</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion</Title><ISOAbbreviation>Endocrinol Nutr</ISOAbbreviation></Journal><ArticleTitle>Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review.</ArticleTitle><Pagination><StartPage>224</StartPage><EndPage>230</EndPage><MedlinePgn>224-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.endonu.2015.02.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1575-0922(15)00078-9</ELocationID><Abstract><AbstractText>Kennedy's disease, also known as bulbospinal muscular atrophy, is a rare, X-linked recessive neurodegenerative disorder affecting adult males. It is caused by expansion of an unstable cytosine-adenine-guanine tandem-repeat in exon 1 of the androgen-receptor gene on chromosome Xq11-12, and is characterized by spinal motor neuron progressive degeneration. Endocrinologically, these patients often have the features of hypogonadism associated to the androgen insensitivity syndrome, particularly its partial forms. We report 4 cases with the typical neurological presentation, consisting of slowly progressing generalized muscle weakness with atrophy and bulbar muscle involvement; these patients also had several endocrine manifestations; the most common non-neurological manifestation was gynecomastia. In all cases reported, molecular analysis showed an abnormal cytosine-adenine-guanine triplet repeat expansion in the androgen receptor gene.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 SEEN. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valera Yepes</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario Bellvitge, L'Hospitalet de Llobregat, Barcelona, Espa&#xf1;a. Electronic address: ro.valera83@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virgili Casas</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario Bellvitge, L'Hospitalet de Llobregat, Barcelona, Espa&#xf1;a. Electronic address: mvirgili@bellvitgehospital.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano Panades</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Universitario Bellvitge, L'Hospitalet de Llobregat, Barcelona, Espa&#xf1;a. Electronic address: mpovedano@bellvitgehospital.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero Gual</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario Bellvitge, L'Hospitalet de Llobregat, Barcelona, Espa&#xf1;a. Electronic address: mguerrero@bellvitgehospital.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villabona Artero</LastName><ForeName>Carles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario Bellvitge, L'Hospitalet de Llobregat, Barcelona, Espa&#xf1;a. Electronic address: cvillabona@bellvitgehospital.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Endocrinol Nutr</MedlineTA><NlmUniqueID>100886482</NlmUniqueID><ISSNLinking>1575-0922</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006728">Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>33515-09-2</RegistryNumber><NameOfSubstance UI="D007987">Gonadotropin-Releasing Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-67-9</RegistryNumber><NameOfSubstance UI="D007986">Luteinizing Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-68-0</RegistryNumber><NameOfSubstance UI="D005640">Follicle Stimulating Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.3.2</RegistryNumber><NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013734" MajorTopicYN="N">Androgen-Insensitivity Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005640" MajorTopicYN="N">Follicle Stimulating Hormone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007987" MajorTopicYN="N">Gonadotropin-Releasing Hormone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006177" MajorTopicYN="N">Gynecomastia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006728" MajorTopicYN="N">Hormones</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007986" MajorTopicYN="N">Luteinizing Hormone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Androgen receptors</Keyword><Keyword MajorTopicYN="N">Atrofia bulbo espinal ligada al X</Keyword><Keyword MajorTopicYN="N">Complete androgen insensitivity syndrome</Keyword><Keyword MajorTopicYN="N">Enfermedades gen&#xe9;ticas ligadas al X</Keyword><Keyword MajorTopicYN="N">Expansi&#xf3;n de la repetici&#xf3;n de trinucle&#xf3;tidos</Keyword><Keyword MajorTopicYN="N">Partial androgen insensitivity syndrome</Keyword><Keyword MajorTopicYN="N">Receptores androg&#xe9;nicos</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de resistencia androg&#xe9;nica completa</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de resistencia androg&#xe9;nica parcial</Keyword><Keyword MajorTopicYN="N">Trinucleotide repeat expansion</Keyword><Keyword MajorTopicYN="N">X-linked bulbospinal atrophy</Keyword><Keyword MajorTopicYN="N">X-linked genetic diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25857692</ArticleId><ArticleId IdType="doi">10.1016/j.endonu.2015.02.008</ArticleId><ArticleId IdType="pii">S1575-0922(15)00078-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>